Kate Ashton
7Patents
4h-index
44Co-inventors
53Inventor score
Filing activity: Nov 19, 2010 → Sep 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10532042B2 | KRAS G12C inhibitors and methods of using the same | Emerging Cross-Sectional Technologies | 36 | Active |
| US11285135B2 | KRAS G12C inhibitors and methods of using the same | Emerging Cross-Sectional Technologies | 13 | Active |
| US10632128B2 | Compounds that inhibit Mcl-1 protein | Chemistry; Metallurgy | 5 | Active |
| US9296698B2 | Amino heteroaryl compounds as beta-secretase modulators and methods of use | Chemistry; Metallurgy | 4 | Active |
| US8431563B2 | Compounds that interact with glucokinase regulatory protein for the treatment of diabetes | Chemistry; Metallurgy | 0 | Active |
| US10821115B2 | Compounds that inhibit Mcl-1 protein | Chemistry; Metallurgy | 0 | Active |
| US11224601B1 | Compounds that inhibits MCL-1 protein | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.